v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 26, 2026
Sep. 27, 2025
Cash flows from operating activities:    
Net income $ 340,816 $ 206,472
Adjustments to reconcile net income to cash used in operating activities:    
Depreciation and amortization 149,337 146,013
Stock-based compensation 34,192 15,107
Non-cash charges for interest and bond discount amortization 14,337 14,090
Amortization of lease right-of-use asset 97,070 92,531
Deferred income taxes (45,591) (17,982)
(Gain) loss on foreign exchange (11,215) 40,763
Loss on sale of subsidiaries 0 38,248
Other 8,979 (11,666)
Changes in operating assets and liabilities, net of effects of acquisitions:    
Trade accounts receivable (1,154,081) 287,900
Inventory (1,659,662) (513,322)
Other assets (180,683) (130,194)
Accounts payable 1,394,503 (519,813)
Change in book overdrafts (114,491) (172,553)
Operating lease liabilities (93,578) (73,576)
Accrued expenses and other (39,663) (46,446)
Cash used in operating activities (1,259,730) (644,428)
Cash flows from investing activities:    
Capital expenditures (109,430) (93,929)
Proceeds from deferred purchase price of factored receivables 128,981 206,507
Issuance of notes receivable (12,375) (12,501)
Proceeds from notes receivable 19,412 31,172
Proceeds from the sale of subsidiaries 0 17,500
Proceeds from sale of equity investments 0 20,805
Other 11,552 13,303
Cash provided by investing activities 38,140 182,857
Cash flows from financing activities:    
Dividends paid to stockholders (61,186) (59,146)
Change in unremitted cash collections from servicing factored receivables (3,514) (2,469)
Repurchase of Common Stock (121,992) 0
Repayment of Term Loans (200,000) (125,000)
Gross proceeds from other debt 58,212 66,716
Gross repayments of other debt (74,051) (79,697)
Net proceeds from revolving and other credit facilities 800,346 528,497
Other (15,801) (13,269)
Cash provided by financing activities 382,014 315,632
Effect of exchange rate changes on cash, cash equivalents and restricted cash (6,634) 30,168
Decrease in cash, cash equivalents and restricted cash (846,210) (115,771)
Cash, cash equivalents and restricted cash at beginning of period 1,864,724 918,401
Cash, cash equivalents and restricted cash at end of period 1,018,514 802,630
Supplemental disclosure of non-cash investing and financing information:    
Amounts obtained as a beneficial interest in exchange for transferring trade receivables in factoring arrangements 106,862 199,643
Amounts reclassified from accounts payable to short-term debt and current maturities of long-term debt $ 114,956 $ 9,553